Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-29 @ 2:23 AM
Study NCT ID:
NCT05968768
Status:
RECRUITING
Last Update Posted:
2025-04-10
First Post:
2023-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Sponsor:
Anna Raciborska
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-13
First Submit QC Date:
None
Study First Post Date:
2023-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-09
Last Update Post Date:
2025-04-10
Last Update Post Date Type:
ACTUAL